Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Simec Atlantis Energy granted Green Economy Mark

(Sharecast News) - Simec Atlantis Energy announced on Friday that it has been granted the Green Economy Mark by the London Stock Exchange. The AIM-traded firm said the mark, introduced in 2019, identifies companies and funds that generate at least 50% of their annual revenues from products and services that contribute to the global green economy.

It said the mark helped investors identify firms significantly involved in environmentally-sustainable activities.

SAE said its focus was on projects aligned with the UK's net zero targets, being a major developer of battery energy storage systems (BESS) in the UK, and with a leading position in tidal stream operations and development.

"We are delighted to have been provided with the Green Economy Mark, demonstrating our clear commitment to being a sustainable business for our planet and our shareholders," said chief executive officer Graham Reid.

"The Green Economy Mark helps ensure that our investors and stakeholders understand our green credentials and our efforts to support the transition to a low carbon economy."

At 0951 BST, shares in Simec Atlantis Energy were up 3.33% at 2.48p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

PepsiCo cuts revenue outlook again
(Sharecast News) - PepsiCo cut its annual organic revenue guidance again on Tuesday as it highlighted a "subdued" performance in North America in the third quarter.
Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.